United States Retinal Vein Occlusion Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Retinal Vein Occlusion (RVO) Market reached US$ 0.93 billion in 2024 and is expected to reach US$ 2.11 billion by 2033, growing at a CAGR of 9.6% during the forecast period 2025-2033.

Recent Mergers and Acquisitions :

United States:

✅ July 2025 - Harrow Inc. acquired the exclusive U.S. commercialization rights to Samsung Bioepis' ophthalmic biosimilar portfolio, including OPUVIZ and BYOOVIZ, which are generic versions of EYLEA and Lucentis.

✅ May 2025 - Regeneron announced positive Phase 3 results for EYLEA HD® (aflibercept 8 mg), showing improved vision with extended dosing intervals.

✅ January 2025 - Regeneron Pharmaceuticals acquired Oxular, a UK-based biotech specializing in ocular delivery technology, to enhance its gene therapy development program.

Japan:

✅ September 2025 - Alvotech received marketing approval in Japan for three new biosimilars, expanding treatment options for retinal diseases.

✅ May 2025 - Bayer submitted aflibercept 8 mg for approval in Japan to treat macular edema following retinal vein occlusion, aiming to offer extended treatment intervals.

✅ May 2025 - Topcon Healthcare acquired RetInSight GmbH, a privately held company based in Vienna, Austria, known for its innovation in retinal imaging AI solutions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/retinal-vein-occlusion-market?sb

Retinal Vein Occlusion (RVO) is a vascular disorder of the eye in which a retinal vein becomes blocked, leading to impaired blood flow, swelling, and vision loss. Management includes anti-VEGF injections, corticosteroids, laser therapy, and treatment of underlying conditions like hypertension or diabetes to preserve vision and prevent complications.

Key Players:

Retinal Vein Occlusion (RVO) Market Major Players:
The major global players in the Retinal vein occlusion (RVO) market are: Bayer AG, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., and AbbVie, among others.

Retinal Vein Occlusion (RVO) Market Emerging Players:
The emerging players in the Retinal vein occlusion (RVO) market include: Sunshine Guojian Pharmaceutical(Shanghai) Co.,Ltd, KODIAK SCIENCES INC., and TAIWAN LIPOSOME CO., LTD., among others.

Growth Forecast Projected:

The Global Retinal Vein Occlusion Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Retinal Vein Occlusion Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=retinal-vein-occlusion-market

Key Segments:

➥ By Type: Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)

➥ By Treatment: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Drugs, Corticosteroids, Laser Therapy, Surgery

Regional Analysis for Retinal Vein Occlusion Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Retinal Vein Occlusion producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Retinal Vein Occlusion revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/retinal-vein-occlusion-market?sb

FAQ

What is the current size of the Retinal Vein Occlusion Market?

A: In 2024, the Retinal Vein Occlusion Market was valued at US$ 0.93 billion, reflecting its strong industry presence.

Q2: How large is the Retinal Vein Occlusion Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Retinal Vein Occlusion Market will grow to around US$ 2.11 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Retinal Vein Occlusion Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 9.6% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.